Answer
Idefirix (imlifidase) is indicated for desensitisation of highly sensitised adult kidney transplant patients with a positive crossmatch against an available deceased donor, reserved for those unlikely to receive a transplant under the available kidney allocation system, including prioritisation programmes for highly sensitised patients.
Sources for this answer
- Idefirix 11 mg powder for concentrate for solution for infusionHansa Biopharma AB · emc · SmPC §4.1 Therapeutic Indications · Version 7Document updated
Sources checked